Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention (Q77933836)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 July 1999

Language	Label	Description	Also known as
English	Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention	scientific article published on 01 July 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Effects of platelet glycoprotein IIb/IIIa inhibition with abciximab on thrombin generation and activity during percutaneous coronary intervention (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sanjeev Kumar Sharma

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

G Dangas

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J D Marmur

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

T E King

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J De Leon

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

R Vidhun

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Feldman

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

M Y Stoynov

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J J Badimon

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

J A Ambrose

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

language of work or name

0 references

publication date

1 July 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

138

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 Pt 1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

49-54

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Characterization of the relative thrombogenicity of atherosclerotic plaque components: Implications for consequences of plaque rupture

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Identification of active tissue factor in human coronary atheroma

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Tissue factor modulates the thrombogenicity of human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Management of restenosis after coronary intervention

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Platelet glycoprotein IIb/IIIa receptor blockade and low-dose heparin during percutaneous coronary revascularization

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein IIb/IIIa complex

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and "clinical restenosis".

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Administration of abciximab during percutaneous coronary intervention reduces both ex vivo platelet thrombus formation and fibrin deposition: implications for a potential anticoagulant effect of abciximab

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

The generation of fibrinopeptide A in clinical blood samples: evidence for thrombin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Unstable angina. A classification

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Correlation of angiographic morphology and clinical presentation in unstable angina.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Role of shear rate and platelets in promoting fibrin formation on rabbit subendothelium. Studies utilizing patients with quantitative and qualitative platelet defects

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Thrombin generation in human coronary arteries after percutaneous transluminal balloon angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Effect of platelet glycoprotein IIb/IIIa integrin blockade on activated clotting time during percutaneous transluminal coronary angioplasty or directional atherectomy (the EPIC trial). Evaluation of c7E3 Fab in the Prevention of Ischemic Complicatio

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

In vitro effects of the platelet glycoprotein IIb/IIIa receptor antagonist c7E3 Fab on the activated clotting time

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2899%2970245-0

7 January 2021

Identifiers

10.1016/S0002-8703(99)70245-0

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10385763%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q77933836&oldid=1753718597"